masthead background

Multi-disciplinary collaboration made easy

Integrating your departments to create a unified patient view for collaborative decision making

Oncology Tumor Board Collaborator thumbnail

Multidisciplinary Team Orchestrator

Virtual Tumor Board solution

Philips solution transforms and enhances the Tumor Board process. It streamlines preparation, enhances review and analysis, and empowers the cancer care team to reach clinical treatment decisions based upon rich dashboards, diagnostic images, reports, and structured patient data. The sessions can be attended virtually or in-person -synchronously or asynchronously.

A solution that supports you every step of the way

Offering based on customers’ needs

Offering based on customer needs

Services that consistently prove their value


Flexible tools that can be customized for your assets intuitive and automated workflows. Seamless integration with systems like EMR, pathology, LIMS, and PACS.


Tailored workflows to capture disease uniqueness.


Robust dashboards and analytics to enable informed decisions.

Virtual tumor board to enable collaborative decision making

laptop image

Digital Pathology

Pathologists are able to open their cases to explain tumor annotations, corresponding quantitative data, and their diagnosis.


Access radiology images and annotations.


Genomic biomarker information.

Advanced visualization

Advanced visualization for enhanced clinical decision support.

Oncology Pathways

In partnership with:

dfci logo

Add clinical trials to your tumor boards

With the exponential growth of clinical trials, it is challenging to consistently keep up with which ones might be beneficial for your patients.

In a recent article posted by ASCO, “patients whose physicians participated in tumor boards weekly had an estimated 60% higher odds of enrolling in a clinical trial than patients whose doctors participated less often or never.”1

This is why we have connected all of our tumor boards to the latest clinical trials through advanced clinical trial matching. Your patients matter to us.

1 Post, The ASCO. “Oncologist Participation in Tumor Board Meetings May Be Associated With Improved Outcomes for Patients With Lung or Colorectal Cancers.” ASCO News, Oct. 2014,

Connect your lab to your tumor board experience banner background

Connect your lab to your tumor board experience

Philips Genomics Workspace provides your oncologists a unified view of relevant therapies and clinical trials in the context of each patient’s unique genomic profile, which can help your clinicians make evidence-based decisions on patient treatment.

seamless interoperable connections background

Seamless interoperable connections

Connecting systems and teams is critical to providing the personalized, end-to-end care patients need. Our tumor board solutions seamlessly connect to your hospital's PACS systems, LIMS systems, EMR, and much more. Our systems are hosted on Philips IntelliBridge Enterprise, ensuring connectivity between departments to readily update your tumor boards with the most up to date information.


Contact information

* This field is mandatory


By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.


Final CEE consent

Genomics Workspace current product name is Pathology Genomics Workspace and Oncology Genomics Workspace. The name of the product will change to Genomics Workspace with the release of ISPM V5.3, subject to regulatory approval.

IntelliSpace Precision Medicine is an information management software only. It does not have the ability to diagnose disease, prescribe treatment, monitor prognosis, alleviate disease, or any other tasks that are constitutive of the practice of medicine.

Oncology Pathways is also known as the Oncology Pathways Navigator. The Oncology Pathways name will be applicable as of ISPM V5.3.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.